Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial

Enriqueta Felip, Heather A. Wakelee, Mark L. McCleland et al.|The Lancet|2021

Cited by 1.5k